Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants

Neurological disorders represent one of the most common disturbances accompanying HIV infection. In the past few years, highly antiretroviral active therapy has significantly reduced the incidence of HIV-related diseases. However, neurological dysfunction in AIDS patients still remains an unresolved problem. Oxidative stress, which occurs in brain tissues of patients undergoing HIV infection and is implicated in cell death of both astroglia and neurones, has recently been suggested to play a role in the pathogenesis of neuroAIDS. Thus, a better understanding of the processes that trigger and modulate free radical formation in brain tissues of AIDS patients might help in a successful therapeutic approach to the neuropathogenesis of HIV infection.

[1]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[2]  S. Cuzzocrea,et al.  A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. , 1999, Science.

[3]  Manisha N. Patel,et al.  Metalloporphyrin class of therapeutic catalytic antioxidants. , 1999, Trends in pharmacological sciences.

[4]  M. Tardieu HIV-1-related central nervous system diseases. , 1999, Current opinion in neurology.

[5]  R. Testi,et al.  Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes , 2000, Journal of leukocyte biology.

[6]  S. Snyder,et al.  Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Stamler,et al.  Redox signaling: Nitrosylation and related target interactions of nitric oxide , 1994, Cell.

[8]  G. Nisticó,et al.  Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase. , 1993, Biochemical and biophysical research communications.

[9]  H. Gendelman,et al.  Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease , 1992, The Journal of experimental medicine.

[10]  L. Epstein,et al.  HIV‐1‐induced neuronal injury in the developing brain , 1999, Journal of leukocyte biology.

[11]  J S Beckman,et al.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. , 1992, Archives of biochemistry and biophysics.

[12]  K. Schwarz,et al.  Oxidative stress during viral infection: a review. , 1996, Free radical biology & medicine.

[13]  S. Pillet,et al.  The role of phagocytes in HIV-related oxidative stress. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[14]  A. Finazzi-Agro’,et al.  Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat , 1999, Neuroscience.

[15]  S. J. Kim,et al.  Suppression of intracellular hydrogen peroxide generation and catalase levels in CD8+ T-lymphocytes from HIV+ individuals. , 1998, Free radical biology & medicine.

[16]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[17]  P. Portegies,et al.  Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. , 1999, Journal of immunology.

[18]  F. Bloom,et al.  Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function 1 Published on the World Wide Web on 24 October 1997. 1 , 1998, Brain Research Reviews.

[19]  M. Currie,et al.  Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin‐induced intestinal damage , 1999, British journal of pharmacology.

[20]  K. Clouse,et al.  Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. , 1999, Blood.

[21]  G. Nisticó,et al.  Release of nitric oxide from astroglial cells: a key mechanism in neuroimmune disorders. , 1995, Advances in neuroimmunology.

[22]  H. Schnaper,et al.  HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. , 1995, Journal of immunology.

[23]  Howard E. Gendelman,et al.  Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .

[24]  M. Roederer,et al.  Glutathione deficiency is associated with impaired survival in HIV disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Curran,et al.  Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia , 1997, Brain Research.

[26]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[27]  H. Gendelman,et al.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. , 1990, Annual review of immunology.

[28]  M. Rice,et al.  Differential compartmentalization of brain ascorbate and glutathione between neurons and glia , 1997, Neuroscience.

[29]  S. Lipton,et al.  Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Cross,et al.  Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[31]  G. Nisticó,et al.  The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro. , 1998, Biochemical pharmacology.

[32]  J. Sidtis,et al.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. , 1988, Science.

[33]  R. Natarajan,et al.  Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways* , 2000, The Journal of Biological Chemistry.

[34]  Y. Hannun,et al.  Platelet-activating Factor Receptor Activation , 1998, The Journal of Biological Chemistry.

[35]  J. Verhoef,et al.  Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia , 2000, Neuropathology and applied neurobiology.

[36]  K. Ikuta,et al.  Amplification of superoxide anion generation in phagocytic cells by HIV‐1 infection , 1993, FEBS letters.

[37]  G. Nisticó,et al.  The effect of nitric oxide on cytokine‐induced release of PGE2 by human cultured astroglial cells , 1998, British journal of pharmacology.

[38]  S. Moncada,et al.  Nitric oxide: from discovery to the clinic. , 1998, Trends in pharmacological sciences.

[39]  Jerry R. Mitchell,et al.  Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. , 1983, The Journal of pharmacology and experimental therapeutics.

[40]  E. Roche,et al.  The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. , 1998, Medical hypotheses.

[41]  J. Weiss,et al.  Mechanisms of leukocyte trafficking into the CNS. , 2000, Journal of neurovirology.

[42]  G. W. Pace,et al.  The role of oxidative stress in HIV disease. , 1995, Free radical biology & medicine.

[43]  A. Cross,et al.  A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[44]  N. Greig,et al.  Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection. , 1999, Neuroreport.

[45]  K. Raivio,et al.  Expression of antioxidant enzymes in human inflammatory cells. , 2000, American journal of physiology. Cell physiology.

[46]  A. Bowie,et al.  Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries. , 2000, Biochemical pharmacology.

[47]  J. Rabkin,et al.  Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function , 1998, AIDS.

[48]  G. Nisticó,et al.  HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. , 1993, Biochemical and biophysical research communications.

[49]  B. K. Park,et al.  The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro. , 2001, Biochemical pharmacology.

[50]  K. Hensley,et al.  Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. , 1999, Life Science.

[51]  H. Gendelman,et al.  Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA , 1995, Molecular and cellular biology.

[52]  F. Ensoli,et al.  Role of immune-derived diffusible mediators in AIDS-associated neurological disorders. , 2000, Archivum immunologiae et therapiae experimentalis.

[53]  H. Forman,et al.  Molecular Mechanism of Decreased Glutathione Content in Human Immunodeficiency Virus Type 1 Tat-transgenic Mice* , 2000, The Journal of Biological Chemistry.

[54]  A. Lazzarin,et al.  Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection Effect of parenteral treatment with SAMe , 1995, Neurology.

[55]  F. Aillet,et al.  Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines. , 1992, Journal of immunology.

[56]  H. Xiong,et al.  HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. , 2000, Journal of neurovirology.